Ginsenoside-Rg1 can effectively ameliorate
mental disorders, but whether ginsenoside-Rg1 plays a neuroprotective role in
cardiac arrest and
cardiopulmonary resuscitation (CA/
CPR)-induced
cognitive impairment remains unclear. In this study, a 5-min
asphyxia-based CA/
CPR rat model was established to explore the mechanisms underlying the effects of ginsenoside-Rg1 (40 mg·kg-1·d-1, ip, 14 days) on its cognitive alterations. These CA/
CPR rats displayed spatial learning and memory impairment in the Morris water maze, as reflected in the compromised basal synaptic transmission and long-term potentiation (LTP) at the Schaffer collateral of hippocampal CA1 area in vivo electrophysiology, whereas the ginsenoside-Rg1 remarkably mitigated these alterations. Next, we found that ginsenoside-Rg1 inhibited hippocampal
neuroinflammation by alleviating the CA/
CPR-induced hippocampal activation of microglia and astrocytes and the overexpression of related proinflammatory
cytokines interleukin-1β (IL-1β) and tumour
necrosis factor-α (TNF-α). In addition, ginsenoside-Rg1 improved CA/
CPR-induced hippocampal neuronal apoptosis, dendritic spines and synaptic ultrastructure defects as associated with the upregulation of the key synaptic regulatory
proteins. Furthermore, ginsenoside-Rg1 could ameliorate CA/
CPR-induced aberrant expression of the key regulators of hippocampal
glutamate signaling pathways,
excitatory amino acid transporter 2 (EAAT2),
excitatory amino acid transporter 1 (EAAT1),
Glutamine Synthetase (GS), GluN2B, and
glutamate. In conclusion, ginsenoside-Rg1 exerts its
neuroprotective effects by ameliorating hippocampus-dependent neuroglia activation-mediated
neuroinflammation and neuroplasticity deficits, shedding new light on the therapeutic intervention of CA/
CPR-related
cognitive disorders.